References
- Bhargava KK, Seshadri TR (1972): Wedelolactone and demethylwedelolactone from Eclipta alba.. J Res Indian Med 9: 9–12.
- Chopra RN, Nayar SL, Chopra IC (1966): Glossary of Indian Medicinal Plants, New Delhi, India, Council of Scientific and Industrial Research, pp. 104–105.
- Das M, Bhavsar GC, Chawhan MG (1990): Spectrophotometric determination of hepatoprotective principles of Eclipta alba.. Indian Drugs 28: 100–102.
- Dixon RA (1984): Callus and suspension culture. In: Dixon RA, ed., Plant Cell Culture: A Practical Approach, ( Practical Approach Series). Oxford, Washington, DC, IRL Press, pp. 14–20.
- Gupta SC, Bajaj UK, Sharma VN (1976): Cardiovascular effects of Eclipta alba. (Hassk.) Bhringraja. J Res Indian Med Yoga Homeopathy 13: 91–95.
- Karnick CR (1989): On comparative values of Indian and Chinese medicinal plants. J Natl Integrated Med Assoc 31: 13–16.
- Karnick CR, Kulkarni M (1990): Ethnobotanical studies of some medicinal plants used in skin diseases. Maharastra Med J 37: 131–134.
- Kulkarni PH (1990): Ayurvedic therapy: Insomnia. Deerghayu International 6: 21.
- Lahkar S (1981): Clinical trials of Rumalaya in osteoarthritis of knee. J Med Surg 21: 21–22.
- Murashige T, Skoog F (1962): A revised medium for rapid growth and bioassay with tobacco tissue culture. Physiol Plant 15: 473–497.
- Saxena AK, Singh B, Anand KK (1993): Hepatoprotective effects of Eclipta alba. on subcellular levels in rats. J Ethanopharmacology 40: 155–161.
- Wagner H, Geyer B, Kiso Y, Rao GS (1986): Coumestans as the main active principle of the liver drug Eclipta alba. and Wadelia calendulacia.. Planta Med 52: 370–373.